SCHEMBL13804483

SCHEMBL13804483

CCNC(=O)OCC1(NC)CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.47
▸ EPHX1 P07099 1/20 0.41
▸ CYP2C9 P11712 1/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CHRNB2 P17787 1/20 0.35
▸ CHRNB4 P30926 1/20 0.35
▸ CHRNA3 P32297 1/20 0.35
▸ CHRNA4 P43681 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ HTR3E A5X5Y0 1/20 0.32
▸ HTR3B O95264 1/20 0.32
▸ HTR3A P46098 1/20 0.32
▸ HTR3D Q70Z44 1/20 0.32
▸ HTR3C Q8WXA8 1/20 0.32
▸ LMNA P02545 1/20 0.30
▸ ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12584816 0.84 CHRNB2 (0.36) ALDH1A1EPHX1CHRNB2CHRNA4SMN1; SMN2
SCHEMBL13792022 0.84 ALDH1A1 (0.45) ALDH1A1EPHX1CYP2C9MEN1KMT2A
SCHEMBL12585586 0.75 CHRNB2 (0.40) CYP2C9MEN1KMT2ACHRNB2CHRNB4
SCHEMBL8374989 0.73 ALDH1A1 (0.54) ALDH1A1EPHX1MEN1KMT2AL3MBTL1
SCHEMBL13791853 0.70 CHRNB2 (0.37) EPHX1CYP2C9CHRNB2CHRNA4SMN1; SMN2
SCHEMBL24920456 0.69 ALDH1A1 (0.37) ALDH1A1CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL6219661 0.68 DPP4 (0.36) HTR3EHTR3BHTR3AHTR3DHTR3C
Hydrochloric Acid SCHEMBL21994477 0.66 ALOX15 (0.38) KMT2ACHRNB2CHRNA4LMNA
SCHEMBL8372462 0.66 EPHX1 (0.43) ALDH1A1EPHX1CYP2C9MEN1KMT2A
SCHEMBL24554762 0.65 DPP4 (0.37) HTR3EHTR3BHTR3AHTR3DHTR3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7550559-B2 Acylsulfonamide compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2009-06-23 — — US disclosed
US-7399749-B2 Substituted prolines as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2008-07-15 — — US disclosed
US-7342041-B2 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease SCHERING CORPORATION (US) 2008-03-11 — — US disclosed
Send feedback